1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015

Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015" provides an overview of Exercise-Induced Bronchoconstriction (EBI) clinical trials scenario. This report provides top line data relating to the clinical trials on Exercise-Induced Bronchoconstriction (EBI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Exercise-Induced Bronchoconstriction (EBI) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Exercise-Induced Bronchoconstriction (EBI) to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Exercise-Induced Bronchoconstriction (EBI) to Respiratory Clinical Trials 19
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 57

List of Tables
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials by Region, 2015* 6
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Exercise-Induced Bronchoconstriction (EBI) to Respiratory Clinical Trials, G7 Countries (%), 2015* 16
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Exercise-Induced Bronchoconstriction (EBI) to Respiratory Clinical Trials, E7 Countries (%), 2015* 20
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List of Figures
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Exercise-Induced Bronchoconstriction (EBI) to Respiratory Clinical Trials, G7 Countries (%), 2015* 15
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Exercise-Induced Bronchoconstriction (EBI) to Respiratory Clinical Trials, E7 Countries (%), 2015* 19
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Exercise-Induced Bronchoconstriction (EBI) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Exercise-Induced Bronchoconstriction (EBI) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 55

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Global Clinical Trials Market

Global Clinical Trials Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) ...

Oncology Devices - Medical Devices Pipeline Assessment, 2016

Oncology Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by GlobalData

Oncology Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Oncology Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.